Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CASTLE BIOSCIENCES INC | Chief Financial Officer | Restricted Stock Units | 48.7K | $1.04M | $21.41 | Mar 4, 2024 | Direct |
CASTLE BIOSCIENCES INC | Chief Financial Officer | Common Stock | 37.7K | $1.01M | $26.83 | Aug 9, 2024 | Direct |
CASTLE BIOSCIENCES INC | Chief Financial Officer | Performance-Based Stock Unit | 9.74K | $261K | $26.83 | Aug 9, 2024 | Direct |
EXAGEN INC. | Director | Stock Option(right to buy) | 9K | Jun 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CSTL | CASTLE BIOSCIENCES INC | Aug 9, 2024 | 3 | -$75.7K | 4 | Aug 13, 2024 | Chief Financial Officer |
CSTL | CASTLE BIOSCIENCES INC | Aug 7, 2024 | 2 | -$257K | 4 | Aug 13, 2024 | Chief Financial Officer |
XGN | EXAGEN INC. | Jun 10, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
CSTL | CASTLE BIOSCIENCES INC | Mar 4, 2024 | 1 | $0 | 4 | Mar 6, 2024 | Chief Financial Officer |
CSTL | CASTLE BIOSCIENCES INC | Dec 9, 2023 | 9 | -$134K | 4 | Dec 12, 2023 | Chief Financial Officer |
XGN | EXAGEN INC. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
CSTL | CASTLE BIOSCIENCES INC | Apr 4, 2023 | 2 | $13.5K | 4 | Apr 5, 2023 | Chief Financial Officer |
CSTL | CASTLE BIOSCIENCES INC | Dec 9, 2022 | 7 | -$53.7K | 4 | Dec 13, 2022 | Chief Financial Officer |
XGN | EXAGEN INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
CSTL | CASTLE BIOSCIENCES INC | May 12, 2022 | 2 | $13.5K | 4 | May 16, 2022 | Chief Financial Officer |
CSTL | CASTLE BIOSCIENCES INC | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | Chief Financial Officer |
CSTL | CASTLE BIOSCIENCES INC | Dec 10, 2021 | 5 | -$36.3K | 4 | Dec 14, 2021 | Chief Financial Officer |
XGN | EXAGEN INC. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
XGN | EXAGEN INC. | Jun 17, 2021 | 0 | $0 | 3 | Jun 21, 2021 | Director |
CSTL | CASTLE BIOSCIENCES INC | Jun 15, 2021 | 9 | -$1.06M | 4 | Jun 17, 2021 | Chief Financial Officer |